RVTY
Revvity, Inc. · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website revvity.com
- Employees(FY) 11000
- ISIN US7140461093
Performance
+0.35%
1W
+0.61%
1M
0.0%
3M
+20.6%
6M
-5.8%
YTD
-19.45%
1Y
Profile
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Investment Analysis Report: RVTY
Overview
RVTY is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. The company has shown consistent growth in market capitalization over the past three years, indicating investor interest in the stock. In this report, we will conduct a detailed analysis of RVTY...
Technical Analysis of RVTY 2024-05-03
Overview:
In analyzing the technical indicators for RVTY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and predictions to guide investment ...
Recent News & Updates
- 2024-05-02 00:47
Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-05-01 12:47
Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-04-30 08:43
- 2024-04-30 07:08
Baird Adjusts Price Target on Revvity to $127 From $126(MT Newswires)
- 2024-04-30 06:06
- 2024-04-30 03:38
- 2024-04-30 03:01
- 2024-04-30 00:15
- 2024-04-29 22:53
- 2024-04-29 22:36
Q1 2024 Revvity Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-04-29 21:30
- 2024-04-29 14:01
Analyst Report: Revvity, Inc.(Morningstar Research)
- 2024-04-29 12:15
- 2024-04-29 10:11
- 2024-04-29 09:51
Nephron Adjusts Revvity's Price Target to $124 From $120(MT Newswires)
- 2024-04-29 09:30
- 2024-04-29 07:39
- 2024-04-29 07:22
- 2024-04-29 07:10
- 2024-04-29 06:08
Revvity: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-04-29 06:00
- 2024-04-28 19:10
- 2024-04-28 18:00
- 2024-04-26 04:15
Revvity Board Declares Quarterly Dividend(Businesswire)
- 2024-04-26 00:50
- 2024-04-25 16:15
Revvity Board Declares Quarterly Dividend(Business Wire)
- 2024-04-25 12:50
- 2024-04-25 08:00
- 2024-04-24 20:00
- 2024-04-24 06:00
Revvity Unveils a New Era of Automated Tuberculosis Testing(Business Wire)
Page 1 of 5
previousnext